Aurora Cannabis (TSE:ACB) Shares Up 8.2%

Aurora Cannabis Inc. (TSE:ACBGet Free Report)’s share price rose 8.2% during trading on Thursday . The company traded as high as C$8.72 and last traded at C$8.70. Approximately 904,213 shares changed hands during mid-day trading, a decline of 26% from the average daily volume of 1,221,178 shares. The stock had previously closed at C$8.04.

Analyst Ratings Changes

Several research analysts have issued reports on the company. CIBC cut their price target on Aurora Cannabis to C$6.00 and set a “neutral” rating on the stock in a report on Wednesday, February 21st. Jefferies Financial Group cut their target price on Aurora Cannabis from C$6.12 to C$4.95 and set a “hold” rating on the stock in a report on Tuesday, February 27th. Finally, Canaccord Genuity Group upgraded shares of Aurora Cannabis from a “hold” rating to a “buy” rating and set a C$0.80 price target for the company in a research note on Friday, February 9th.

Read Our Latest Research Report on Aurora Cannabis

Aurora Cannabis Price Performance

The stock has a market capitalization of C$487.04 million, a P/E ratio of -0.11 and a beta of 2.83. The business has a fifty day simple moving average of C$5.06 and a 200 day simple moving average of C$2.18. The company has a current ratio of 3.79, a quick ratio of 2.48 and a debt-to-equity ratio of 18.51.

Aurora Cannabis (TSE:ACBGet Free Report) last announced its earnings results on Thursday, February 8th. The company reported C($0.20) earnings per share (EPS) for the quarter, missing the consensus estimate of C($0.10) by C($0.10). The company had revenue of C$72.61 million for the quarter, compared to analysts’ expectations of C$63.50 million. Aurora Cannabis had a net margin of 151.71% and a negative return on equity of 137.28%. On average, analysts expect that Aurora Cannabis Inc. will post -0.22 earnings per share for the current year.

About Aurora Cannabis

(Get Free Report)

Aurora Cannabis Inc, together with its subsidiaries, produces, distributes, and sells cannabis and cannabis-derivative products in Canada and internationally. It operates through three segments: Canadian Cannabis, European Cannabis, and Plant Propagation. The company produces, distributes, and sells medical and consumer cannabis products in Canada.

Further Reading

Receive News & Ratings for Aurora Cannabis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aurora Cannabis and related companies with MarketBeat.com's FREE daily email newsletter.